
Randeep Singh
Examiner (ID: 641, Phone: (571)270-3881 , Office: P/1615 )
| Most Active Art Unit | 1615 |
| Art Unit(s) | 1615 |
| Total Applications | 524 |
| Issued Applications | 328 |
| Pending Applications | 7 |
| Abandoned Applications | 192 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11789474
[patent_doc_number] => 09399010
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-07-26
[patent_title] => 'Nail enamel compositions having decorative voids'
[patent_app_type] => utility
[patent_app_number] => 13/788235
[patent_app_country] => US
[patent_app_date] => 2013-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6949
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 130
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13788235
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/788235 | Nail enamel compositions having decorative voids | Mar 6, 2013 | Issued |
Array
(
[id] => 9719751
[patent_doc_number] => 20140255451
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-11
[patent_title] => 'Implantable Medical Device Comprising A Macrocyclic Triene Lactone Drug And Minimal Antioxidant Stabilizer And Method Of Fabrication'
[patent_app_type] => utility
[patent_app_number] => 13/788584
[patent_app_country] => US
[patent_app_date] => 2013-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 8709
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13788584
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/788584 | Implantable Medical Device Comprising A Macrocyclic Triene Lactone Drug And Minimal Antioxidant Stabilizer And Method Of Fabrication | Mar 6, 2013 | Abandoned |
Array
(
[id] => 12166056
[patent_doc_number] => 09884816
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-02-06
[patent_title] => 'Sulforaphane-derived compounds, production method thereof and the medical, food and cosmetic use of same'
[patent_app_type] => utility
[patent_app_number] => 14/383780
[patent_app_country] => US
[patent_app_date] => 2013-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 6
[patent_no_of_words] => 10634
[patent_no_of_claims] => 38
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14383780
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/383780 | Sulforaphane-derived compounds, production method thereof and the medical, food and cosmetic use of same | Mar 5, 2013 | Issued |
Array
(
[id] => 10247388
[patent_doc_number] => 20150132384
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-14
[patent_title] => 'POLYMERIC NANOPARTICLES USEFUL IN THERANOSTICS'
[patent_app_type] => utility
[patent_app_number] => 14/382495
[patent_app_country] => US
[patent_app_date] => 2013-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 65
[patent_figures_cnt] => 65
[patent_no_of_words] => 30677
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14382495
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/382495 | Polymeric nanoparticles useful in theranostics | Mar 3, 2013 | Issued |
Array
(
[id] => 9004572
[patent_doc_number] => 20130225697
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-29
[patent_title] => 'TAMPER-RESISTANT DOSAGE FORM COMPRISING PHARMACOLOGICALLY ACTIVE COMPOUND AND ANIONIC POLYMER'
[patent_app_type] => utility
[patent_app_number] => 13/778186
[patent_app_country] => US
[patent_app_date] => 2013-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 25510
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13778186
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/778186 | TAMPER-RESISTANT DOSAGE FORM COMPRISING PHARMACOLOGICALLY ACTIVE COMPOUND AND ANIONIC POLYMER | Feb 26, 2013 | Abandoned |
Array
(
[id] => 8962929
[patent_doc_number] => 20130202531
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-08
[patent_title] => 'INDICATORS FOR DETECTING THE PRESENCE OF METABOLIC BYPRODUCTS FROM MICROORGANISMS'
[patent_app_type] => utility
[patent_app_number] => 13/777849
[patent_app_country] => US
[patent_app_date] => 2013-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 13272
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13777849
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/777849 | INDICATORS FOR DETECTING THE PRESENCE OF METABOLIC BYPRODUCTS FROM MICROORGANISMS | Feb 25, 2013 | Abandoned |
Array
(
[id] => 9813075
[patent_doc_number] => 20150025020
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-22
[patent_title] => 'SELF-PRESERVED OIL DISPERSIONS COMPRISING BORIC ACID'
[patent_app_type] => utility
[patent_app_number] => 14/380655
[patent_app_country] => US
[patent_app_date] => 2013-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7521
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14380655
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/380655 | Self-preserved oil dispersions comprising boric acid | Feb 21, 2013 | Issued |
Array
(
[id] => 9957459
[patent_doc_number] => 09005659
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-04-14
[patent_title] => 'Pharmaceutical formulation containing gelling agent'
[patent_app_type] => utility
[patent_app_number] => 13/765368
[patent_app_country] => US
[patent_app_date] => 2013-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20184
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13765368
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/765368 | Pharmaceutical formulation containing gelling agent | Feb 11, 2013 | Issued |
Array
(
[id] => 9957459
[patent_doc_number] => 09005659
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-04-14
[patent_title] => 'Pharmaceutical formulation containing gelling agent'
[patent_app_type] => utility
[patent_app_number] => 13/765368
[patent_app_country] => US
[patent_app_date] => 2013-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20184
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13765368
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/765368 | Pharmaceutical formulation containing gelling agent | Feb 11, 2013 | Issued |
Array
(
[id] => 9957459
[patent_doc_number] => 09005659
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-04-14
[patent_title] => 'Pharmaceutical formulation containing gelling agent'
[patent_app_type] => utility
[patent_app_number] => 13/765368
[patent_app_country] => US
[patent_app_date] => 2013-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20184
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13765368
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/765368 | Pharmaceutical formulation containing gelling agent | Feb 11, 2013 | Issued |
Array
(
[id] => 9957459
[patent_doc_number] => 09005659
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-04-14
[patent_title] => 'Pharmaceutical formulation containing gelling agent'
[patent_app_type] => utility
[patent_app_number] => 13/765368
[patent_app_country] => US
[patent_app_date] => 2013-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20184
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13765368
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/765368 | Pharmaceutical formulation containing gelling agent | Feb 11, 2013 | Issued |
Array
(
[id] => 8862026
[patent_doc_number] => 20130145729
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-06-13
[patent_title] => 'Methods of Providing Antioxidants to Implantable Medical Devices'
[patent_app_type] => utility
[patent_app_number] => 13/760540
[patent_app_country] => US
[patent_app_date] => 2013-02-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11957
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13760540
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/760540 | Methods of Providing Antioxidants to Implantable Medical Devices | Feb 5, 2013 | Abandoned |
Array
(
[id] => 11721089
[patent_doc_number] => 09693935
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-07-04
[patent_title] => 'Personal care solid granules that sustain essential oils and or plant herbal extracts that emulsify in hot water creating therapeutic solution'
[patent_app_type] => utility
[patent_app_number] => 13/740235
[patent_app_country] => US
[patent_app_date] => 2013-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 2252
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 193
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13740235
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/740235 | Personal care solid granules that sustain essential oils and or plant herbal extracts that emulsify in hot water creating therapeutic solution | Jan 12, 2013 | Issued |
Array
(
[id] => 10240533
[patent_doc_number] => 20150125528
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-07
[patent_title] => 'CONTROLLED RELEASE APPARATUS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/370584
[patent_app_country] => US
[patent_app_date] => 2013-01-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 8407
[patent_no_of_claims] => 62
[patent_no_of_ind_claims] => 23
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14370584
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/370584 | CONTROLLED RELEASE APPARATUS AND USES THEREOF | Jan 3, 2013 | Abandoned |
Array
(
[id] => 10837517
[patent_doc_number] => 08865189
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-10-21
[patent_title] => 'Poly(ester amide)-based drug delivery systems'
[patent_app_type] => utility
[patent_app_number] => 13/731875
[patent_app_country] => US
[patent_app_date] => 2012-12-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6046
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13731875
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/731875 | Poly(ester amide)-based drug delivery systems | Dec 30, 2012 | Issued |
Array
(
[id] => 10102710
[patent_doc_number] => 09138481
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-09-22
[patent_title] => 'Cellulosic gel composition with improved viscosity stability'
[patent_app_type] => utility
[patent_app_number] => 13/687315
[patent_app_country] => US
[patent_app_date] => 2012-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 4275
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13687315
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/687315 | Cellulosic gel composition with improved viscosity stability | Nov 27, 2012 | Issued |
Array
(
[id] => 9490669
[patent_doc_number] => 20140141075
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-22
[patent_title] => '5-AMINOSALICYLIC ACID CAPSULE FORMULATION'
[patent_app_type] => utility
[patent_app_number] => 13/683080
[patent_app_country] => US
[patent_app_date] => 2012-11-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9625
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13683080
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/683080 | 5-AMINOSALICYLIC ACID CAPSULE FORMULATION | Nov 20, 2012 | Abandoned |
Array
(
[id] => 8732718
[patent_doc_number] => 20130078287
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-03-28
[patent_title] => 'PHARMACEUTICAL COMPOSITIONS OF IBUPROFEN AND AN H2 RECEPTOR ANTAGONIST'
[patent_app_type] => utility
[patent_app_number] => 13/681275
[patent_app_country] => US
[patent_app_date] => 2012-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 22085
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13681275
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/681275 | PHARMACEUTICAL COMPOSITIONS OF IBUPROFEN AND AN H2 RECEPTOR ANTAGONIST | Nov 18, 2012 | Abandoned |
Array
(
[id] => 8841081
[patent_doc_number] => 20130136709
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-05-30
[patent_title] => 'SYNERGISTICALLY ACTING TERNARY ANTIMICROBIAL MIXTURES'
[patent_app_type] => utility
[patent_app_number] => 13/668560
[patent_app_country] => US
[patent_app_date] => 2012-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8261
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13668560
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/668560 | Synergistically acting ternary antimicrobial mixtures | Nov 4, 2012 | Issued |
Array
(
[id] => 9450101
[patent_doc_number] => 20140121271
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-05-01
[patent_title] => 'NON-ENZYMATIC REMOVAL OF HYDROGEN PEROXIDE FROM PERACIDS'
[patent_app_type] => utility
[patent_app_number] => 13/661208
[patent_app_country] => US
[patent_app_date] => 2012-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16022
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13661208
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/661208 | Non-enzymatic removal of hydrogen peroxide from peracids | Oct 25, 2012 | Issued |